更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。
米国
- 2025.11.03
- 2025.11.03
New
October 31, 2025
- Phenobarbital Tablet (Discontinuation)
October 29, 2025
- Moxifloxacin Injection (Discontinuation)
October 27, 2025
- Pramlintide Acetate Injection (Discontinuation)
Updated
期間中、新たな報告はありません。
カナダ
カナダの情報はありません。
オーストラリア
- 2025.11.03
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated clozapine Oral Liquid, suspension 50 mg/mL Current Unavailable Manufacturing 3/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 3/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 3/11/2025 bleomycin sulfate Injection, powder for 15000 IU Anticipated Available Manufacturing 3/11/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated 1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/11/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .125 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/11/2025 saxagliptin~dapagliflozin propanediol monohydrate Tablet 5 mg~12.3 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 1/11/2025 dinoprostone Gel .3333 mg/g Anticipated Available Manufacturing 1/11/2025 betiatide Injection, powder for 1 mg Anticipated Available Manufacturing 31/10/2025 phenylephrine hydrochloride Injection, solution 10 mg/mL Anticipated Available Manufacturing 31/10/2025 phenoxymethylpenicillin potassium Oral Liquid, powder for 28.284 mg/mL Resolved Available Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 31/10/2025 bisoprolol fumarate Tablet 2.5 mg Resolved Available Manufacturing 31/10/2025 phenobarbital Tablet, uncoated 30 mg Current Limited Availability Manufacturing 31/10/2025 escitalopram oxalate Tablet, film coated 25.548 mg Current Limited Availability Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Unexpected increase in consumer demand 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Unexpected increase in consumer demand 31/10/2025 bimatoprost Eye Drops .3 mg/mL Current Unavailable Manufacturing 31/10/2025 linezolid Tablet, film coated 600 mg Current Unavailable Manufacturing 31/10/2025 irbesartan Tablet, film coated 300 mg Anticipated Available Manufacturing 31/10/2025 irbesartan Tablet, film coated 150 mg Anticipated Available Manufacturing 31/10/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 31/10/2025 olmesartan medoxomil~amlodipine besilate Tablet, film coated 20 mg~6.935 mg Anticipated Available Manufacturing 31/10/2025 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 31/10/2025 rasagiline mesilate Tablet 1.56 mg Current Unavailable Manufacturing 31/10/2025 ambrisentan Tablet, film coated 5 mg Current Limited Availability Manufacturing 31/10/2025 lorazepam Tablet 1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 31/10/2025 hyoscine butylbromide Injection, solution 20 mg Current Limited Availability Manufacturing 31/10/2025 daptomycin Injection, powder for 500 mg Current Limited Availability Manufacturing 31/10/2025 fentanyl citrate Injection, solution 785 microgram Resolved Available Manufacturing 31/10/2025 famciclovir Tablet, film coated 250 mg Resolved Available Manufacturing 31/10/2025 famciclovir Tablet, film coated 500 mg Resolved Available Manufacturing 31/10/2025 lidocaine hydrochloride monohydrate Injection, solution 10 mg/mL Resolved Available Manufacturing 31/10/2025 lidocaine hydrochloride monohydrate Injection, solution 10 mg/mL Current Limited Availability Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .25 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 31/10/2025 lamotrigine Tablet, dispersible 200 mg Anticipated Available Manufacturing 31/10/2025 rifampicin Oral Liquid 20 mg/mL Anticipated Available Unexpected increase in consumer demand 30/10/2025 galantamine hydrobromide Capsule, modified release 20.512 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 30/10/2025 mesalazine Tablet, modified release 1 g Resolved Available Transport / Logistic issues / Storage capacity issues 30/10/2025 lansoprazole Capsule, enteric 30 mg Current Limited Availability Manufacturing 30/10/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Current Limited Availability Manufacturing 30/10/2025 metronidazole Tablet, uncoated 400 mg Current Limited Availability Manufacturing 30/10/2025 naproxen Oral Liquid, suspension 25 mg/mL Resolved Available Manufacturing 30/10/2025 risperidone Tablet, film coated 3 mg Current Limited Availability Manufacturing 30/10/2025 quetiapine fumarate Tablet, modified release 345.39 mg Anticipated Available Manufacturing 30/10/2025 pramipexole dihydrochloride monohydrate Tablet, modified release .75 mg Resolved Available Manufacturing 30/10/2025 pramipexole dihydrochloride monohydrate Tablet, modified release .375 mg Resolved Available Manufacturing 30/10/2025 pramipexole dihydrochloride monohydrate Tablet, modified release 1.5 mg Resolved Available Manufacturing 30/10/2025 pramipexole dihydrochloride monohydrate Tablet, modified release 2.25 mg Resolved Available Manufacturing 30/10/2025 hydrochlorothiazide~irbesartan Tablet, film coated 12.5 mg~300 mg Resolved Available Manufacturing 30/10/2025 atenolol Tablet, film coated 50 mg Resolved Available Manufacturing 30/10/2025 latanoprost Eye Drops, solution .05 mg/mL Anticipated Available Manufacturing 30/10/2025 erlotinib hydrochloride Tablet, film coated 27.32 mg Current Unavailable Unexpected increase in consumer demand 30/10/2025 carvedilol Tablet, film coated 6.25 mg Resolved Available Manufacturing 30/10/2025 thiotepa Injection, powder for 15 mg Current Unavailable Commercial Changes / Commercial viability 30/10/2025 thiotepa Injection, powder for 100 mg Current Unavailable Commercial Changes / Commercial viability 30/10/2025 thiotepa Injection, powder for 400 mg Current Unavailable Commercial Changes / Commercial viability 30/10/2025 Teriparatide Injection, solution .25 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 30/10/2025 phenytoin sodium Injection, solution 250 mg Current Limited Availability Manufacturing 30/10/2025 mianserin hydrochloride Tablet, film coated 20 mg Current Limited Availability Manufacturing 30/10/2025 methyldopa sesquihydrate Tablet, film coated 283 mg Current Limited Availability Manufacturing 30/10/2025 pamidronate disodium Injection, concentrated 3 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/10/2025 nizatidine Capsule 300 mg Anticipated Available Manufacturing 30/10/2025 simvastatin Tablet, film coated 5 mg Anticipated Available Manufacturing 30/10/2025 verapamil hydrochloride~trandolapril Tablet, film coated 240 mg~4 mg Resolved Available Manufacturing 29/10/2025 calcium polystyrene sulfonate Powder 999.3 mg/g Anticipated Available Manufacturing 29/10/2025 risperidone Tablet, film coated 1 mg Resolved Available Manufacturing 29/10/2025 pentetic acid Injection, powder for 5 mg Current Unavailable Manufacturing 29/10/2025 medronic acid Injection, powder for 10 mg Current Unavailable Manufacturing 29/10/2025 sildenafil citrate Tablet, uncoated 35.1 mg Resolved Available Manufacturing 29/10/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 29/10/2025 ceftazidime pentahydrate Injection, powder for 2.328 g Current Limited Availability Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Current Limited Availability Manufacturing 29/10/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.9 mg Current Unavailable Unexpected increase in consumer demand 29/10/2025 temozolomide Capsule, hard 5 mg Current Limited Availability Manufacturing 29/10/2025 sodium nitroprusside Injection, solution 50 mg Anticipated Available Manufacturing 29/10/2025 tobramycin Capsule, hard 28 mg Anticipated Available Manufacturing 29/10/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Limited Availability Manufacturing 29/10/2025 atorvastatin calcium trihydrate~amlodipine besilate Tablet, film coated 43.376 mg~13.88 mg Current Limited Availability Manufacturing 29/10/2025 phenoxymethylpenicillin potassium Tablet, film coated 560 mg Current Limited Availability Manufacturing 29/10/2025 rosuvastatin calcium Tablet, film coated 41.68 mg Current Unavailable Manufacturing 29/10/2025 pregabalin Capsule, hard 75 mg Resolved Available Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 29/10/2025 mesalazine Tablet, enteric coated 800 mg Resolved Available Transport / Logistic issues / Storage capacity issues 29/10/2025 hydrocortisone Tablet, uncoated 4 mg Current Limited Availability Manufacturing 29/10/2025 tadalafil Tablet, film coated 5 mg Resolved Available Manufacturing 29/10/2025 risperidone Tablet, film coated .5 mg Anticipated Available Commercial Changes / Commercial viability 29/10/2025 risperidone Tablet, film coated 1 mg Current Unavailable Commercial Changes / Commercial viability 29/10/2025 risperidone Tablet, film coated 2 mg Current Unavailable Commercial Changes / Commercial viability 29/10/2025 risperidone Tablet, film coated 3 mg Current Unavailable Commercial Changes / Commercial viability 29/10/2025 risperidone Tablet, film coated 4 mg Current Unavailable Commercial Changes / Commercial viability 29/10/2025 fluorouracil Injection, solution 50 mg/mL Resolved Available Unexpected increase in consumer demand 29/10/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 29/10/2025 lurasidone hydrochloride Tablet, film coated 40 mg Resolved Available Manufacturing 29/10/2025 lurasidone hydrochloride Tablet, film coated 80 mg Resolved Available Manufacturing 29/10/2025 amiodarone hydrochloride Tablet, uncoated 100 mg Resolved Available Manufacturing 29/10/2025 spironolactone Tablet, uncoated 100 mg Resolved Available Manufacturing 29/10/2025 lenalidomide Capsule 5 mg Resolved Available Manufacturing 29/10/2025 sugammadex sodium Injection, solution 217.6 mg Resolved Available Manufacturing 29/10/2025 hydrocortisone hydrogen succinate Injection, powder for 127.6 mg Anticipated Available Manufacturing 29/10/2025 levothyroxine sodium Tablet 50 microgram Resolved Available Unexpected increase in consumer demand 29/10/2025 levothyroxine sodium Tablet 100 microgram Resolved Available Unexpected increase in consumer demand 29/10/2025 sodium chloride Injection, intravenous infusion 9 g/L Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 29/10/2025 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 29/10/2025 labetalol hydrochloride Tablet, film coated 100 mg Current Unavailable Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Current Unavailable Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Current Unavailable Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Unavailable Manufacturing 29/10/2025 amoxicillin sodium Injection, powder for 1060 mg Resolved Available Manufacturing 29/10/2025 Rubella virus~Measles virus~live varicella vaccine~Mumps virus Injection, powder for 1000 CCID50~1000 CCID50~1995 PFU~25119 CCID50 Resolved Available Manufacturing 28/10/2025 prazosin hydrochloride Tablet, uncoated 2.19 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 28/10/2025 prazosin hydrochloride Tablet, uncoated 5.476 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 28/10/2025 salbutamol sulfate Inhalation, conventional 6 mg Current Unavailable Manufacturing 28/10/2025 stannous chloride~etifenin Injection, powder for .42 mg~20 mg Current Unavailable Manufacturing 28/10/2025 Somatropin Injection, powder for 12 mg/mL Current Limited Availability Unexpected increase in consumer demand 28/10/2025 hydrocortisone sodium succinate Injection, powder for 134 mg Resolved Available Manufacturing 28/10/2025 enalapril maleate Tablet 5 mg Current Limited Availability Manufacturing 28/10/2025 alfentanil hydrochloride Injection, solution 1.0876 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/10/2025 doxylamine succinate Tablet, uncoated 25 mg Current Limited Availability Unexpected increase in consumer demand 28/10/2025 quetiapine fumarate Tablet, modified release 57.5 mg Anticipated Available Unexpected increase in consumer demand 28/10/2025 peramivir Injection, concentrated 10 mg/mL Anticipated Available Commercial Changes / Commercial viability 28/10/2025 topotecan hydrochloride Injection, concentrated 4.346 mg Current Limited Availability Unexpected increase in consumer demand 28/10/2025 stannous chloride dihydrate Injection, powder for 19.2 microgram/mL Resolved Available Manufacturing 28/10/2025 Interferon gamma1b Injection, solution 4 million IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/10/2025 risperidone Injection, modified release 50 mg Anticipated Available Manufacturing 28/10/2025 Insulin glulisine Injection, solution 3.49 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/10/2025 lidocaine hydrochloride Injection, solution 10 mg/mL Resolved Available Manufacturing 27/10/2025 simvastatin~ezetimibe Tablet 80 mg~10 mg Anticipated Available Manufacturing 27/10/2025 ezetimibe~simvastatin Tablet 10 mg~40 mg Anticipated Available Manufacturing 27/10/2025 donepezil hydrochloride Tablet, film coated 5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 27/10/2025 cyproterone acetate Tablet, uncoated 100 mg Anticipated Available Manufacturing 27/10/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 27/10/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 10.341 mg~10 mg Resolved Available Manufacturing 27/10/2025 emtricitabine~tenofovir disoproxil succinate Tablet, film coated 200 mg~300.6 mg Current Limited Availability Manufacturing 27/10/2025 pentamidine isetionate Injection, powder for 300 mg Anticipated Available Manufacturing 27/10/2025 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 27/10/2025 GluureaLys(ahx)hbedCC Injection, powder for 25 microgram Current Unavailable Manufacturing 27/10/2025 GluureaLys(ahx)hbedCC Injection, powder for 25 microgram Current Unavailable Manufacturing 27/10/2025 iotroxate meglumine Injection, solution 105.46 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 27/10/2025 galantamine hydrobromide~galantamine Capsule, modified release 20.51 mg~16 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 27/10/2025
ドイツ
- 2025.11.03
Active ingredients Message type Date of last message Type of reason AM designation Nimodipine Change notification 31.10.2025 Other Nimotop S Galantamine hydrobromide Change notification 31.10.2025 Other Galantamine – 1A Pharma 24 mg delayed-release hard capsules Nimodipine Initial report 31.10.2025 Other Nimotop Galantamine hydrobromide Change notification 31.10.2025 Other Galantamine – 1A Pharma 16 mg delayed-release hard capsules Sertraline hydrochloride Initial report 31.10.2025 Other Zoloft 20 mg/ml concentrate for oral solution Ciprofloxacin hydrochloride monohydrate Change notification 30.10.2025 Other CIPRO BASICS 750 mg film-coated tablets Ciprofloxacin hydrochloride monohydrate Change notification 30.10.2025 Other CIPRO BASICS 250 mg film-coated tablets Atorvastatin calcium trihydrate (Ph.Eur.) Change notification 30.10.2025 Other ATORVASTATIN BASICS 80 mg film-coated tablets Ezetimibe; simvastatin Change notification 30.10.2025 Production problem EZETIMIB/SIMVA BASICS 10 mg/80 mg tablets Ezetimibe; simvastatin Change notification 30.10.2025 Production problem EZETIMIB/SIMVA BASICS 10 mg/40 mg tablets Ezetimibe; simvastatin Change notification 30.10.2025 Production problem EZETIMIB/SIMVA BASICS 10 mg/20 mg tablets Ezetimibe; simvastatin Change notification 30.10.2025 Production problem EZETIMIBE/SIMVA BASICS 10 mg/10 mg tablets Esomeprazole hemimagnesium Change notification 30.10.2025 Production problem ESOMEPRAZOLE BASICS 20 mg gastro-resistant hard capsules Esomeprazole hemimagnesium Change notification 30.10.2025 Production problem ESOMEPRAZOLE BASICS 40 mg gastro-resistant hard capsules Isotretinoin Change notification 30.10.2025 Other ISOTRETINOIN BASICS 10 mg soft capsules Isophan insulin suspension for injection (Ph.Eur.) Initial report 30.10.2025 Other Protaphane Penfill 100 IU/ml injection suspension in cylinder ampoule – OP(10x3ml) Flecainide acetate Change notification 30.10.2025 Other Tambocor Moxifloxacin hydrochloride (Ph.Eur.) ((with information on water content (1:x))) Change notification 30.10.2025 Other Moxifloxacin Holsten 400 mg film-coated tablets Doxepin hydrochloride (Ph.Eur.) Initial report 30.10.2025 Other Doxepin 50 Holsten Alprazolam Change notification 30.10.2025 Other Alprazolam – 1 A Pharma 1 mg tablets Oxcarbazepine Change notification 30.10.2025 Other Oxcarbazepine – 1 A Pharma 60 mg/ml oral suspension Flutamide Change notification 30.10.2025 Production problem FLUTA-cell 250 mg tablets Voriconazole Initial report 29.10.2025 Other VFEND 200 mg film-coated tablets Doxepin hydrochloride (Ph.Eur.) Change notification 29.10.2025 Other Doxepin 75 Holsten Doxepin hydrochloride (Ph.Eur.) Change notification 29.10.2025 Production problem Doxepin 25 Holsten Methylphenidate hydrochloride Change notification 29.10.2025 Other Methylphenidate AL 36 mg prolonged-release tablets Methylphenidate hydrochloride Change notification 29.10.2025 Other Metiphenal 10 mg modified-release hard capsules Posaconazole Change notification 29.10.2025 Other Posaconazole AL 40 mg/ml oral suspension Methylphenidate hydrochloride Change notification 29.10.2025 Other Methylphenidate AL 27 mg prolonged-release tablets Aprepitant Change notification 29.10.2025 Other Aprepitant AL 80 mg hard capsules Levothyroxine sodium Change notification 28.10.2025 Production problem L-thyroxine Henning 125 (4′-O-(13)C)Methacetin Change notification 28.10.2025 Production problem LiMAxetin 4 mg/ml solution for injection Besilesomab Initial report 28.10.2025 Production problem Scintimun Besilesomab Initial report 28.10.2025 Production problem Scintimun Levetiracetam Change notification 28.10.2025 Other Levetiracetam – 1 A Pharma 1500 mg film-coated tablets Olanzapine embonate monohydrate Initial report 28.10.2025 Production problem ZYPADHERA 210 mg powder and solvent for the preparation of a prolonged-release suspension for injection – OP(483mg+3ml) Paliperidone palmitate Initial report 28.10.2025 Other Paliperidone AL 25 mg prolonged-release injection suspension in a pre-filled syringe Paliperidone palmitate Change notification 28.10.2025 Other Paliperidone AL 50 mg depot injection suspension in a pre-filled syringe Olanzapine Change notification 28.10.2025 Production problem ZYPREXA Fluphenazine decanoate Change notification 28.10.2025 Production problem Fluphenazine-neuraxpharm D 50 mg/0.5 ml Fluphenazine decanoate Change notification 28.10.2025 Production problem Fluphenazine-neuraxpharm D 12.5 mg/0.5 ml Fluphenazine decanoate Change notification 28.10.2025 Production problem Fluphenazine-neuraxpharm D 25 mg/ml Fluphenazine decanoate Change notification 28.10.2025 Production problem Fluphenazine-neuraxpharm D 100 mg/ml Atomoxetine hydrochloride Change notification 28.10.2025 Production problem Atomoxetine-neuraxpharm 60 mg hard capsules Atomoxetine hydrochloride Change notification 28.10.2025 Production problem Atomoxetine-neuraxpharm 10 mg hard capsules Atomoxetine hydrochloride Change notification 28.10.2025 Production problem Atomoxetine-neuraxpharm 18 mg hard capsules Atomoxetine hydrochloride Change notification 28.10.2025 Production problem Atomoxetine-neuraxpharm 25 mg hard capsules Atomoxetine hydrochloride Change notification 28.10.2025 Production problem Atomoxetine-neuraxpharm 40 mg hard capsules Atomoxetine hydrochloride Change notification 28.10.2025 Production problem Atomoxetine-neuraxpharm 80 mg hard capsules Atomoxetine hydrochloride Change notification 28.10.2025 Production problem Atomoxetine-neuraxpharm 100 mg hard capsules Haloperidol decanoate Change notification 28.10.2025 Production problem Haloperidol-neuraxpharm decanoate 50 mg/ml Haloperidol decanoate Change notification 28.10.2025 Production problem Haloperidol-neuraxpharm decanoate 100 mg/ml Quetiapine fumarate (Ph.Eur.) Change notification 28.10.2025 Other Quetiapine-neuraxpharm 50 mg prolonged-release tablets Quetiapine fumarate (Ph.Eur.) Change notification 28.10.2025 Other Quetiapine-neuraxpharm 150 mg prolonged-release tablets Flutamide Change notification 28.10.2025 Other Flutamide AL 250 Quetiapine fumarate (Ph.Eur.) Change notification 28.10.2025 Other Quetiapine-neuraxpharm 200 mg prolonged-release tablets Quetiapine fumarate (Ph.Eur.) Change notification 28.10.2025 Other Quetiapine-neuraxpharm 300 mg prolonged-release tablets Quetiapine fumarate (Ph.Eur.) Change notification 28.10.2025 Other Quetiapine-neuraxpharm 400 mg prolonged-release tablets Quetiapine fumarate (Ph.Eur.) Change notification 28.10.2025 Other Quetiapine-neuraxpharm 600 mg prolonged-release tablets Biperiden hydrochloride Change notification 28.10.2025 Production problem Biperiden-neuraxpharm 2 mg Biperiden hydrochloride Change notification 28.10.2025 Production problem Biperiden-neuraxpharm 4 mg Methylphenidate hydrochloride Change notification 28.10.2025 Other Methylphenidate hydrochloride-neuraxpharm 27 mg prolonged-release tablets Sodium (methylprednisolone-21-succinate) Change notification 28.10.2025 Other Urbason soluble forte 1000 mg Isosorbide mononitrate Change notification 28.10.2025 Production problem ISMN STADA 50 mg hard capsules, delayed release Aprepitant Change notification 28.10.2025 Production problem Aprepitant STADA 125 mg and 80 mg hard capsules Pramipexole dihydrochloride monohydrate Change notification 28.10.2025 Production problem Pramipexole STADA 0.52 mg prolonged-release tablets Aprepitant Change notification 28.10.2025 Production problem Aprepitant STADA 80 mg hard capsules Aprepitant Change notification 28.10.2025 Production problem Aprepitant STADA 125 mg hard capsules Gabapentin Change notification 27.10.2025 Other Gabapentin Holsten 100 mg hard capsules Tetrabenazine Initial report 27.10.2025 Other Tetrabenazine Aristo 25 mg tablets Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) Change notification 27.10.2025 Other Ferrlecit 62.5 mg Cefaclor monohydrate Change notification 27.10.2025 Other Cefaclor 125 TS – 1 A Pharma Methyldopa (Ph.Eur.) Change notification 27.10.2025 Other Dopegyt tablets Insulin glargine Change notification 27.10.2025 Other Semglee 100 units/ml solution for injection in pre-filled pen – OP(5x3ml) Sufentanil citrate Initial report 27.10.2025 Production problem Sufenta mite Arsenic(III) oxide Change notification 27.10.2025 Production problem Arsenic trioxide STADA 1 mg/ml concentrate for solution for infusion
フランス
- 2025.11.03
Active ingredients Statut Update Specialty caffeine, opium (dry extract of), paracetamol Supply tension 31/10/2025 Lamaline, suppository mesalazine Supply tension 31/10/2025 Pentasa 1 g and 2 g, granules in sachets, and Pentasa 1 g, suppositories demeclocycline hydrochloride Stock shortage 31/10/2025 Alkonatrem 150 mg, capsule Immunoglobuline humaine rabique Marketing discontinuation 31/10/2025 Imogam Rage 150 UI/mL, solution injectable clarithromycin Return to availability 31/10/2025 Clarithromycin, 250 and 500 mg, modified-release film-coated tablet and film-coated tablet clarithromycin Return to availability 31/10/2025 Clarithromycin Arrow 25 mg/mL, granules for oral suspension clarithromycin Return to availability 31/10/2025 Clarithromycin 50 mg/mL, granules for oral suspension Return to availability 31/10/2025 Copper 6 mg/1 mL Histidine 117.20 mg/3 mL AP-HP, injectable solution, CIPH code 77772737 chlorpromazine (hydrochloride) Stock shortage 31/10/2025 Largactil 100 mg, film-coated tablet acide ascorbique Supply tension 10/30/2025 Laroscorbine 1 g/5 ml, solution injectable I.V. en ampoule tobramycin Supply tension 10/30/2025 Tobi Podhaler 28 mg, powder for inhalation in capsules cytarabine Return to availability 10/30/2025 Cytarabine Sandoz 100 mg/mL, solution for injection – 1 glass vial(s) of 50 mL varenicline (tartrate) Supply tension 10/30/2025 Champix 0.5 mg and 1 mg, film-coated tablet fluorouracil Supply tension 29/10/2025 Fluorouracil Accord 50 mg/mL, solution for dilution for infusion, 5 mL and 100 mL vials methylprednisolone (sodium hydrogen succinate) Return to availability 29/10/2025 Methylprednisolone Hikma 40 mg, powder for solution for injection lithium (carbonate) Supply tension 29/10/2025 Teralithe 250 mg, breakable tablet lithium (carbonate) Supply tension 29/10/2025 Teralithe LP 400 mg, extended-release breakable tablet bromfenac sodium sesquihydrate Supply tension 28/10/2025 Yellox 0.9 mg/mL, eye drops, solution epoetin beta Supply tension 28/10/2025 NeoRecormon range, injectable solution in pre-filled syringe temozolomide Supply tension 28/10/2025 Temodal 2.5 mg/mL, powder for solution for infusion methylprednisolone (sodium hydrogen succinate) Supply tension 28/10/2025 Methylprednisolone Hikma 500 mg, powder for solution for injection tolvaptan Supply tension 27/10/2025 Jinarc 15 mg tablet + Jinarc 45 mg tablet tolvaptan Stock shortage 27/10/2025 Tolvaptan Teva 15 mg tablet + Tolvaptan Teva 45 mg tablet cyanocobalamin Supply tension 27/10/2025 Vitamin B12 Delagrange 1000 micrograms/2 mL, injectable (IM) and oral solution tolvaptan Stock shortage 27/10/2025 Tolvaptan Biogaran 15 mg, tablet + Tolvaptan Biogaran 45 mg, tablet
英国
英国の情報はありません。
EU
EUの情報はありません。